Competence in Custom Monoclonal Antibody Development

BioGenes specialises in highly sophisticated monoclonal antibody development. Our scientists have successfully developed monoclonal antibodies against all kinds of antigens: peptides, soluble proteins, membrane proteins, phosphorylated antigens, small organic molecules like haptens, oligo- and polysaccharides as well as animal cells and highly toxic substances.

A specialist for complex projects

BioGenes does more than routine antibody development!
Our scientists are specialized in complex projects and have developed monoclonal antibodies that detect modified proteins and peptides from non-modified (e.g. phosphorylation, methylation, etc.) as well as anti-idiotypic antibodies. Moreover, they have successfully managed projects with small antibody amounts and antigen mixtures, and developed monoclonal antibodies against target proteins from cell extracts.

BioGenes delivers premium quality monoclonal antibodies in 3-4 months. Only 0.2 mg of antigen or antigen mixtures are sufficient for monoclonal antibody development.

Thanks to our extensive experience in hybridoma development we are able to offer monoclonal antibodies with guaranteed success.

Antibodies developed by BioGenes are a valuable basis for therapeutic antibody development and an appropriate tool for validating targets in proteomics research.

For checking cross reactivities, we offer antibody characterisation using UNIchip® Biochips. Discuss, plan and realise your project with us.

BioGenes will prove to be a reliable and qualified partner!